From the editor.
J Dianne
JD
Garner
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077610:Bexarotene; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D051379:Mice; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene